EyeGage
EyeGage is a technology company.
Financial History
EyeGage has raised $260K across 1 funding round.
Frequently Asked Questions
How much funding has EyeGage raised?
EyeGage has raised $260K in total across 1 funding round.
EyeGage is a technology company.
EyeGage has raised $260K across 1 funding round.
EyeGage has raised $260K in total across 1 funding round.
EyeGage is a technology company developing AI-powered drug and alcohol screening software that analyzes eye characteristics via mobile devices to detect impairment and prevent accidents in high-risk environments.[1][2][4] The product uses computer vision to assess pupil size, sclera color, involuntary twitching, and reaction time, categorizing substances into alcohol, marijuana, amphetamines, opiates, and benzodiazepines, serving sectors like transportation, construction, manufacturing, hospitals, airlines, law enforcement, and insurance.[1][2][4][6] It solves the problem of slow, invasive traditional testing by offering quick, non-invasive, contactless scans with instant results, saving time, money, and lives while improving safety and compliance.[2][4]
EyeGage targets high-risk workplaces and individuals operating vehicles, heavy equipment, or medical tools, with potential embeds in safety auto OEMs.[4] Growth momentum includes selection as a Venture Atlanta 2022 Showcase Company from 450+ applicants, participation in AWS Impact Accelerator for scaling machine learning via Amazon SageMaker, expansion to Georgia Tech's ATDC in 2021, a pre-seed raise in April 2021 enabling team growth, and plans for seed funding in late 2021 to collect 10,000 eye datasets and secure pilots in transportation and construction.[2][3][5]
EyeGage was founded by Dr. LaVonda Brown, an expert in artificial intelligence and eye-analysis technologies, who developed a patented robotic engagement model based on eye gaze and pupil dilation initially for applications like math education, physical therapy, mild cognitive impairment detection, and early-onset Alzheimer’s.[3] Business operations began in 2020 from Brown's Downtown Atlanta loft, driven by her vision to apply eye tracking as a biomarker for drug and alcohol impairment to prevent fatal accidents.[3][5] Early traction included a pre-seed raise closing in April 2021, which funded team expansion and relocation in August 2021 to the Advanced Technology Development Center (ATDC) on Georgia Tech’s campus.[5] Pivotal moments feature developing an iOS data collection app by mobile developer Fredrick Burns and boosting productivity through Acting CTO Alonzo Patterson, Jr., setting the stage for seed funding and pilots.[1][5]
EyeGage rides the wave of AI-driven computer vision and telemedicine trends, shifting drug screening from invasive methods to instant mobile scans amid rising gig economy demands and workplace safety regulations.[1][2][3] Timing aligns with post-2020 remote work evolution, substance abuse impacts from the pandemic, and $6.5B+ in Southeast tech funding via events like Venture Atlanta, where it was showcased.[2] Market forces favoring it include labor shortages in high-risk industries (construction, transportation), insurance cost pressures, and OEM interest in embedded safety tech, plus AWS partnerships enabling ML scaling.[3][4][5] It influences the ecosystem by pioneering eye biomarkers for health/safety, potentially standardizing contactless screening and inspiring datasets for broader diagnostics.[3]
EyeGage is positioned for expansion through pilot contracts, larger datasets, and seed funding to refine AI accuracy and enter new verticals like automotive embeds and health diagnostics.[3][5] Trends like AI democratization via cloud platforms, regulatory pushes for impairment tech, and multimodal biomarkers will accelerate adoption, evolving its role from niche safety tool to ecosystem-wide standard.[2][3] As high-risk sectors prioritize prevention, EyeGage's eye-powered innovation could redefine accident reduction, building on its Atlanta roots to scale nationally.
EyeGage has raised $260K in total across 1 funding round.
EyeGage's investors include Jumpstart Foundry.
EyeGage has raised $260K across 1 funding round. Most recently, it raised $260K Seed in September 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2021 | $260K Seed | Jumpstart Foundry |